Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONS4-Hydroxyphenylacetic acid is a phenolic acid with anti-inflammatory and anti-steatotic activities.1,2 It is formed via microbial metabolism of aromatic amino acids and polyphenolic compounds, including flavonoid glycosides, by gut microbiota.3,4,5 4-Hydroxyphenylacetic acid (100 mg/kg) inhibits seawater instillation-induced increases in TNF-α, IL-1β, and IL-6 levels in lung tissue and white blood cell numbers in bronchoalveolar lavage fluid (BALF) and prevents lung edema in a rat model of acute lung injury.1 It reverses hepatic steatosis in a mouse model of high-fat diet-induced obesity when administered via a subcutaneous implant at a dose of 350 µg/day for two weeks.2 Levels of 4-hydroxyphenylacetic acid are increased and decreased in serum and urine, respectively, in rats fed a high-fat diet.3 Serum levels of 4-hydroxyphenylacetic acid are increased in patients with stage III pancreatic cancer.6
WARNING This product is not for human or veterinary use.
1. 4-
2. A gut microbial metabolite of dietary polyphenols reverses obesity-
3. Targeted metabolomics for the quantitative measurement of 9 gut microbiota-
4. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch. Pharm. Res. 21(1), 17-23 (1998).
5. Biotransformation of tea polyphenols by gut microbiota. J. Funct. Foods 7, 26-42 (2014).
6. Serum metabolomics as a novel diagnostic approach for pancreatic cancer. Metabolomics 6(4), 518–528 (2010).